Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy

Author(s):: Asten, J.J.A. van; Vettukattil, R.; Buckle, T.; Rottenberg, S.; Leeuwen, F. van; Bathen, T.F.; Heerschap, A.

Published: 2015
Publication type: Article / Letter to editor

Date issued: 2015-04-09
Language: English
Is part of: Journal of Translational Medicine
hdl: 1887/106339
doi: 10.1186/s12967-015-0458-4